BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 9305659)

  • 1. Natural history of hepatitis C.
    Seeff LB
    Hepatology; 1997 Sep; 26(3 Suppl 1):21S-28S. PubMed ID: 9305659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: A National Heart, Lung, and Blood Institute collaborative study.
    Seeff LB; Hollinger FB; Alter HJ; Wright EC; Cain CM; Buskell ZJ; Ishak KG; Iber FL; Toro D; Samanta A; Koretz RL; Perrillo RP; Goodman ZD; Knodell RG; Gitnick G; Morgan TR; Schiff ER; Lasky S; Stevens C; Vlahcevic RZ; Weinshel E; Tanwandee T; Lin HJ; Barbosa L
    Hepatology; 2001 Feb; 33(2):455-63. PubMed ID: 11172349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to hepatocellular carcinoma.
    Leone N; Rizzetto M
    Minerva Gastroenterol Dietol; 2005 Mar; 51(1):31-46. PubMed ID: 15756144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in the treatment of hepatitis C.
    Lawrence SP
    Adv Intern Med; 2000; 45():65-105. PubMed ID: 10635046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical picture and evolution of hepatitis C].
    Marcellin P; Erlinger S
    Bull Acad Natl Med; 1996; 180(6):1267-76; discussion 1276-8. PubMed ID: 8991608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late liver-related mortality from complications of transfusion-acquired hepatitis C.
    Kamitsukasa H; Harada H; Tanaka H; Yagura M; Tokita H; Ohbayashi A
    Hepatology; 2005 Apr; 41(4):819-25. PubMed ID: 15793849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C and hepatocellular carcinoma.
    Di Bisceglie AM
    Hepatology; 1997 Sep; 26(3 Suppl 1):34S-38S. PubMed ID: 9305661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of long-term outcomes of community-acquired hepatitis C infection in a cohort with sera stored from 1971 to 1975.
    Rodger AJ; Roberts S; Lanigan A; Bowden S; Brown T; Crofts N
    Hepatology; 2000 Sep; 32(3):582-7. PubMed ID: 10960453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of recurrent HCV infection after liver transplantation].
    Ostojić R
    Acta Med Croatica; 2005; 59(5):443-6. PubMed ID: 16381241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcome of hepatitis C as a function of mode of transmission.
    Gordon SC; Bayati N; Silverman AL
    Hepatology; 1998 Aug; 28(2):562-7. PubMed ID: 9696025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term morbidity and mortality risk in Japanese insurance applicants with chronic hepatitis C virus infection.
    Pokorski RJ
    J Insur Med; 2001; 33(1):12-36. PubMed ID: 11317876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies for assessing the long-term consequences of Hepatitis C virus infection.
    Seeff LB
    Minerva Gastroenterol Dietol; 2000 Dec; 46(4):207-16. PubMed ID: 16501439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The natural history of hepatitis C: clinical experiences.
    Müller R
    J Hepatol; 1996; 24(2 Suppl):52-4. PubMed ID: 8836889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural history of hepatitis C and the impact of anti-viral therapy.
    Boyer N; Marcellin P
    Forum (Genova); 2000; 10(1):4-18. PubMed ID: 10717254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The natural history of childhood-acquired hepatitis C infection in patients with inherited bleeding disorders.
    Posthouwer D; Fischer K; van Erpecum KJ; Mauser-Bunschoten EP
    Transfusion; 2006 Aug; 46(8):1360-6. PubMed ID: 16934072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum insulin-like growth factor I evaluation as a useful tool for predicting the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a prospective study.
    Mazziotti G; Sorvillo F; Morisco F; Carbone A; Rotondi M; Stornaiuolo G; Precone DF; Cioffi M; Gaeta GB; Caporaso N; Carella C
    Cancer; 2002 Dec; 95(12):2539-45. PubMed ID: 12467068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcomes after transfusion-associated hepatitis C.
    Tong MJ; el-Farra NS; Reikes AR; Co RL
    N Engl J Med; 1995 Jun; 332(22):1463-6. PubMed ID: 7739682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome of vertically acquired and post-transfusion hepatitis C infection in children.
    Rerksuppaphol S; Hardikar W; Dore GJ
    J Gastroenterol Hepatol; 2004 Dec; 19(12):1357-62. PubMed ID: 15610308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrosing cholestatic hepatitis in renal transplant recipients with hepatitis C virus infection.
    Delladetsima JK; Boletis JN; Makris F; Psichogiou M; Kostakis A; Hatzakis A
    Liver Transpl Surg; 1999 Jul; 5(4):294-300. PubMed ID: 10388502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nine-year follow-up of hepatitis C virus infection in a rural area of Hebei province, China].
    Fan WM; Zhu WF; Zhang SY; Wang QX; Yin LM; Wan H; Gao Y; Tian XL; Yu M; Jin J; Xu XY; Wei L; Zhuang H
    Zhonghua Yi Xue Za Zhi; 2004 Mar; 84(5):392-6. PubMed ID: 15061992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.